Vitamin C was the first vitamin to be manufactured by chemical synthesis on an industrial scale, and today more vitamin C is produced than any other vitamin. Major suppliers of vitamin C are Hoffmann‐La Roche, BASF, Takeda, and Merck‐Darmstadt. Additional production occurs in Eastern Europe, India, and China. Most of the current industrial production is based on the efficient second synthesis developed by Reichstein and Grüssner in 1934. Various attempts to develop a superior, more economical
L
‐ascorbic acid process have been reported since 1934. Much time and effort has been developed to find other methods of vitamin C synthesis by fermentation. The use of the fermentation process for the cost‐effective production of
L
‐ascorbic acid, however, requires further improvement.
Both epidemiological and biochemical studies indicate that vitamin C may play an important role in the prevention of cancer, cataracts, and other disorders. However, there are many gaps in the knowledge of vitamin C, eg, in its role in nutritional interrelationships and in metabolic interactions, as well as its role in prevention of various diseases in humans.
Although much additional knowledge concerning the various factors affecting the ascorbic acid status of humans has been acquired in the past decade, the optimum ascorbic acid intake necessary to maintain peak physical and mental health still needs to be established.